As of Jul 14, 2025, Insight Molecular Diagnostics Inc. has 2,560 shares failed to deliver, representing 3.36% of the average daily volume of 76,208 shares. Over the past year, the monthly average FTD is 15,410 shares, with the current level 83% below the historical average, indicating low settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.